Functional Visual Loss

Neurologic Clinics

Volumn 28, Issue 3, 2010, Pages 789-802

  Bruce, Beau B ^a   Newman, Nancy J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Functional visual loss; Nonorganic visual loss

Indexed keywords

BINOCULAR VISION; HOSPITAL MANAGEMENT; HUMAN; MEDICOLEGAL ASPECT; MENTAL DISEASE; NEOPLASM; NEUROOPHTHALMOLOGY; PERIMETRY; PRIORITY JOURNAL; REVIEW; STEREOSCOPIC VISION; STROKE; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; BLINDNESS; COMPLICATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VISION TEST;

BLINDNESS; HUMANS; MENTAL DISORDERS; VISION TESTS; VISUAL ACUITY; VISUAL FIELDS;

EID: 77954735716     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2010.03.012     Document Type: Review

References (63)

1. Berlin R.M., Ronthal M., Bixler E.O., et al. Psychiatric symptomatology in an outpatient neurology clinic. J Clin Psychiatry 1983, 44(6):204-206.
2. Kirk C., Saunders M. Primary psychiatric illness in a neurological out-patient department in North East England. An assessment of symptomatology. Acta Psychiatr Scand 1977, 56(4):294-302.
3. Kirk C.A., Saunders M. Psychiatric illness in a neurological out-patient department in North East England. Use of the General Health Questionnaire in the prospective study of neurological out-patients. Acta Psychiatr Scand 1979, 60(5):427-437.
4. Biousse V, Newman NJ Nonorganic neuro-ophthalmic symptoms and signs. Neuro-ophthalmology illustrated 2009, Thieme, New York, 501-10.
5. Miller N.R. Neuro-ophthalmologic manifestations of nonorganic disease. Walsh and Hoyt's clinical neuro-ophthalmology 2005, vol. 2:1315-1334. Lippincott William & Wilkins, Philadelphia. 6th edition. N.R. Miller, N.J. Newman (Eds.).
6. Newman N.J. Neuro-ophthalmology and psychiatry. Gen Hosp Psychiatry 1993, 15(2):102-114.
7. Wasfy I.A., Wasfy E., Aly T.A., et al. Ophthalmic medicolegal cases in Upper Egypt. Int Arch Med 2009, 2(1):1.
8. Mavrakanas N.A., Schutz J.S. Feigned visual loss misdiagnosed as occult traumatic optic neuropathy: diagnostic guidelines and medical-legal issues. Surv Ophthalmol 2009, 54(3):412-416.
9. Miller B.W. A review of practical tests for ocular malingering and hysteria. Surv Ophthalmol 1973, 17(4):241-246.
10. Kathol R.G., Cox T.A., Corbett J.J., et al. Functional visual loss: I. A true psychiatric disorder?. Psychol Med 1983, 13(2):307-314.
11. Kramer K.K., La Piana F.G., Appleton B. Ocular malingering and hysteria: diagnosis and management. Surv Ophthalmol 1979, 24(2):89-96.
12. Keane J.R. Neuro-ophthalmic signs and symptoms of hysteria. Neurology 1982, 32(7):757-762.
13. Smith C.H., Beck R.W., Mills R.P. Functional disease in neuro-ophthalmology. Neurol Clin 1983, 1(4):955-971.
14. Keltner J.L., May W.N., Johnson C.A., et al. The California syndrome. Functional visual complaints with potential economic impact. Ophthalmology 1985, 92(3):427-435.
15. Thompson H.S. Functional visual loss. Am J Ophthalmol 1985, 100(1):209-213.
16. Scott J.A., Egan R.A. Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol 2003, 135(5):670-675.
17. Ney J.J., Volpe N.J., Liu G.T., et al. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology 2009, 116(9):1808-1813. e1801.
18. American Psychiatric Association Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th edition.
19. Levy N.S., Glick E.B. Stereoscopic perception and Snellen visual acuity. Am J Ophthalmol 1974, 78(4):722-724.
20. Golnik K.C., Lee A.G., Eggenberger E.R. The monocular vertical prism dissociation test. Am J Ophthalmol 2004, 137(1):135-137.
21. Chen C.S., Lee A.W., Karagiannis A., et al. Practical clinical approaches to functional visual loss. J Clin Neurosci 2007, 14(1):1-7.
22. Zinkernagel S.M., Mojon D.S. Distance doubling visual acuity test: a reliable test for nonorganic visual loss. Graefes Arch Clin Exp Ophthalmol 2009, 247(6):855-858.
23. Bengtzen R., Woodward M., Lynn M.J., et al. The " sunglasses sign" predicts nonorganic visual loss in neuro-ophthalmologic practice. Neurology 2008, 70(3):218-221.
24. Keane J.R. Hysterical hemianopia. The 'missing half' field defect. Arch Ophthalmol 1979, 97(5):865-866.
25. Mills R.P., Glaser J.S. Hysterical bitemporal hemianopia. Arch Ophthalmol 1981, 99(11):2053.
26. Massicotte E.C., Semela L., Hedges T.R. Multifocal visual evoked potential in nonorganic visual field loss. Arch Ophthalmol 2005, 123(3):364-367.
27. Bumgartner J., Epstein C.M. Voluntary alteration of visual evoked potentials. Ann Neurol 1982, 12(5):475-478.
28. Reiss A.B., Biousse V., Yin H., et al. Voluntary alteration of full-field electroretinogram. Am J Ophthalmol 2005, 139(3):571-572.
29. Rover J., Bach M. Pattern electroretinogram plus visual evoked potential: a decisive test in patients suspected of malingering. Doc Ophthalmol 1987, 66(3):245-251.
30. Vrabec T.R., Affel E.L., Gaughan J.P., et al. Voluntary suppression of the multifocal electroretinogram. Ophthalmology 2004, 111(1):169-176.
31. Moster M.L., Galetta S.L., Schatz N.J. Physiologic functional imaging in " functional" visual loss. Surv Ophthalmol 1996, 40(5):395-399.
32. Kathol R.G., Cox T.A., Corbett J.J., et al. Functional visual loss: II. Psychiatric aspects in 42 patients followed for 4 years. Psychol Med 1983, 13(2):315-324.
33. Kathol R.G., Cox T.A., Corbett J.J., et al. Functional visual loss. Follow-up of 42 cases. Arch Ophthalmol 1983, 101(5):729-735.
34. Krill A.E., Newell F.W. The diagnosis of ocular conversion reaction involving visual function. Arch Ophthalmol 1968, 79(3):254-261.
35. van Balen A.T., Slijper F.E. Psychogenic amblyopia in children. J Pediatr Ophthalmol Strabismus 1978, 15(3):164-167.
36. Linhart W.O. Field findings in functional disease; report of 63 cases. Am J Ophthalmol 1956, 42(1):75-84.
37. Friesen H., Mann W.A. Follow-up study of hysterical amblyopia. Am J Ophthalmol 1966, 62(6):1106-1115.
38. Rada R.T., Meyer G.G., Krill A.E. Visual conversion reaction in children. I. Diagnosis. Psychosomatics 1969, 10(1):23-28.
39. Gross M.P., Sloan S.H. Patients with eye symptoms and no organic illness: an interdisciplinary study. Psychiatry Med 1971, 2(4):298-307.
40. Lim S.A., Siatkowski R.M., Farris B.K. Functional visual loss in adults and children patient characteristics, management, and outcomes. Ophthalmology 2005, 112(10):1821-1828.
41. Taich A., Crowe S., Kosmorsky G.S., et al. Prevalence of psychosocial disturbances in children with nonorganic visual loss. J AAPOS 2004, 8(5):457-461.
42. Babinski J. Demembrement de l'hysterie traditionnelle: pithiatisme. La Semaine Medicale 1909, 29:3-8. [in French].
43. Hall R.C.W. Psychiatric presentations of medical illness: somatopsychic disorders 1980, Scientific & Medical Books, Springer (NY).
44. Hayes J.R., Butler N.E., Martin C.R. Misunderstood somatopsychic concomitants of medical disorders. Psychosomatics 1986, 27(2):128-130. 133.
45. Cummings J.L. Organic psychosis. Psychosomatics 1988, 29(1):16-26.
46. Binder R.L. Neurologically silent brain tumors in psychiatric hospital admissions: three cases and a review. J Clin Psychiatry 1983, 44(3):94-97.
47. Cohen S.I. Cushing's syndrome: a psychiatric study of 29 patients. Br J Psychiatry 1980, 136:120-124.
48. Kelly W.F., Checkley S.A., Bender D.A., et al. Cushing's syndrome and depression-a prospective study of 26 patients. Br J Psychiatry 1983, 142:16-19.
49. Baskin D.S., Wilson C.B. Surgical management of craniopharyngiomas. A review of 74 cases. J Neurosurg 1986, 65(1):22-27.
50. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977, 87(3):336-345.
51. Stern B.J., Krumholz A., Johns C., et al. Sarcoidosis and its neurological manifestations. Arch Neurol 1985, 42(9):909-917.
52. Heffernan A., Cullen M., Towers R., et al. Sarcoidosis of the hypothalamus. A case report with a review of the literature. Hormones 1971, 2(1):1-12.
53. Sawyer R.A., Selhorst J.B., Zimmerman L.E., et al. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976, 81(5):606-613.
54. Thirkill C.E., Roth A.M., Keltner J.L. Cancer-associated retinopathy. Arch Ophthalmol 1987, 105(3):372-375.
55. Thirkill C.E., FitzGerald P., Sergott R.C., et al. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells. N Engl J Med 1989, 321(23):1589-1594.
56. Caplan L.R. " Top of the basilar" syndrome. Neurology 1980, 30(1):72-79.
57. Katz B., Rimmer S. Ophthalmologic manifestations of Alzheimer's disease. Surv Ophthalmol 1989, 34(1):31-43.
58. Mendez M.F., Mendez M.A., Martin R., et al. Complex visual disturbances in Alzheimer's disease. Neurology 1990, 40(3 Pt 1):439-443.
59. Fraunfelder F.T., Meyer S.M. Ocular toxicology. Clinical ophthalmology 1988, vol. 5. J.B. Lippincott, Philadelphia. T.D. Duane (Ed.).
60. Grant W.M. Toxicology of the eye 1986, Charles C. Thomas, Springfield (IL).
61. May R.H., Selymes P., Weekley R.D., et al. Thioridazine therapy: results and complications. J Nerv Ment Dis 1960, 130:230.
62. Meredith T.A., Aaberg T.M., Willerson W.D. Progressive chorioretinopathy after receiving thioridazine. Arch Ophthalmol 1978, 96(7):1172-1176.
63. Li J., Tripathi R.C., Tripathi B.J. Drug-induced ocular disorders. Drug Saf 2008, 31(2):127-141.